New Open Financial Posting, Sr. Director of Financial Planning & Analysis (FP&A), Protagonist Therapeutics
Protagonist Therapeutics is seeking a Senior Director of Financial Planning & Analysis (FP&A) to head our financial planning and analysis and play a key role in the Finance organization. Reporting to the CFO, Senior Director of FP&A will have ownership of financial planning and analysis and be responsible for the creation and maintenance of financial models, forecasts, reports and Key Performance Indicators. Working directly with the senior team, this position will play a lead role in strategic planning, assessing operational and investment decisions, and developing success criteria. The Senior Director of FP&A will focus on the analytics that support strategic financial planning, budgets, forecasting, asset valuation, monthly financial reporting, and portfolio management.

The Senior Director, FP&A is accountable for providing sound financial analysis to support the development of the company’s overall business strategy, developing insightful information from the company’s internal accounting and financial reports, delivering executive level presentations, and synthesizing and articulating key findings for executive and operations management audiences. The Senior Director of FP&A will advise and support the company’s executive team including preparing board and financial presentations, industry/peer group comparisons, new business initiatives, and opportunities assessment, and is a key resource for the company’s corporate development initiatives.

The candidate will demonstrate the ability to understand and apply various principles and possess a deep knowledge of the Corporate, Commercial and R&D operations in the biopharmaceutical industry to solve a wide range of challenges, raise business issues, and identify and implement process improvement opportunities. A strong candidate will have a demonstrated ability to communicate to peers, clients and top management in a clear and concise manner. As the Company’s first full-time position within the FP&A area, the candidate will display the willingness and ability to operate independently supporting many business needs at all levels required to achieve our corporate goals and objectives.


  • Ownership of the FP&A function, including financial planning and tracking of operating expenses, headcount reporting, monthly close support, quarterly forecasting, annual budgeting, and variance analyses
  • Advisor to the senior teams on the financial performance of the business and produce board and management reporting packages;
  • Lead the organization in the annual operating plan process and conduct financial forecasts and budget analyses;
  • Lead periodic business reviews to analyze results and key information and conduct sensitivity and risk analysis and development of recommendations;
  • Provide direction to and implement departmental policies to ensure proper accounting treatment of PO’s & expenses;
  • Support the business development department on valuation and financial aspects of collaboration agreements and other corporate development projects, including analyses supporting program-related investment decisions;
  • Partners with project team lead/members and department heads to ensure consistency between corporate goals, project timelines, and project financial plans;
  • Owns consolidation & ongoing reporting of the Corporate Long-Range Planning model to business owners and finance team;
  • Conducts ad hoc financial modeling to support tactical and strategic decision making such as business case development, cost analysis, and sensitivity analyses;
  • Provides financial management and oversight over contracts as well as any key partnerships, collaborations or licensing deals;
  • Participates on special projects as assigned;
  • Complies with corporate policies and procedures, as well as, US healthcare laws and regulations.


  • 12+ years of progressive experience and demonstrated growth including a minimum of 5 years in Finance/FP&A required;
  • Biotechnology/pharmaceutical industries experience required including working knowledge of clinical development;
  • Highly proficient developing complex in business models;
  • Demonstrated ability to perform trend analyses and forecasting;
  • Excellent interpersonal skills with a demonstrated ability to work effectively with multiple functional areas in a collaborative, team environment;
  • Strong verbal and written communication skills to effectively influence business partners and decisions on optimal decisions for the company;
  • Ability to exercise sound judgment and work independently with minimal supervision and/or guidance;
  • Well organized and a strong attention detail; ability to effectively adopt/implement systematic approaches in order to maximize efficiencies and scalability;
  • Prior experience with ERP systems, Financial Planning tools, and other financial systems implementations preferred
  • Positive work ethic, superb communication, and organizational skills with high attention to detail, and unquestionable integrity and personal ethics
  • Demonstrated ability to thrive in a dynamic and fast-paced environment with the ability to think strategically Successful experience in a fast-paced entrepreneurial environment;

About Protagonist Therapeutics, Inc.

Protagonist Therapeutics is a clinical stage biopharmaceutical company that utilizes a proprietary technology platform to discover and develop novel peptide-based drugs to transform existing treatment paradigms for patients with significant unmet medical needs. PTG-200 is an oral peptide interleukin-23 receptor antagonist in development for the treatment of Crohn's disease, and it has completed Phase 1 studies in healthy volunteers. The company has entered into a worldwide license and collaboration agreement with Janssen Biotech for the clinical development of PTG-200. PN-10943 is an oral, gut-restricted alpha-4-beta-7 integrin antagonist peptide that is under development for treatment of ulcerative colitis. Protagonist is also developing an injectable hepcidin mimetic, PTG-300, for the potential treatment of anemia and iron overload related to rare blood diseases with an initial focus on beta thalassemia. A global Phase 2 trial in patients with beta thalassemia will be initiated by the end of 2018.

Protagonist is headquartered in Newark, California, with pre-clinical and clinical staff in California and discovery operations in both California and Brisbane, Queensland, Australia. For further information, please visit

The Assocation of Bioscience Financial Officers

Interested in this opportunity?

Please contact Carena Spivey at

To view this html email as a web page in your browser, please use this link.

To see this and other open financial positions with our ABFO member companies,
please visit our ABFO website job posting page



You are receiving this notice because you have indicated interest in ABFO, are an ABFO Member Representative, or have come to one of our meetings.
If you have questions or comments or wish to be removed from our distribution list,
please contact the ABFO Membership Coordinator, Genie Hawkins at